ENVOY MEDICAL, INC. Net Income
ENVOY MEDICAL, INC. (COCH) reported Net Income of -$5.98 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2026-08-10
- ENVOY MEDICAL, INC. net income (loss) attributable to parent for the quarter ending 2026-06-30 was -$5.98M.
- ENVOY MEDICAL, INC. net income (loss) attributable to parent for the quarter ending 2026-03-31 was -$4.35M.
- ENVOY MEDICAL, INC. net income (loss) attributable to parent for the quarter ending 2025-12-31 was -$6.59M.
- ENVOY MEDICAL, INC. net income (loss) attributable to parent for the quarter ending 2025-09-30 was -$6.48M.
- ENVOY MEDICAL, INC. net income (loss) attributable to parent for fiscal 2023 was -$29.92M.
- ENVOY MEDICAL, INC. net income (loss) attributable to parent for fiscal 2022 was -$15.92M.
- ENVOY MEDICAL, INC. net income (loss) attributable to parent for fiscal 2021 was -$251.63K.
| Period end | Net Income (Loss) Attributable to Parent 0 month | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 3 month as first filed | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 6 month as first filed | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 9 month as first filed | Net Income (Loss) Attributable to Parent 12 month | Net Income (Loss) Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$5.98M 10-Q · filed 2026-08-10 | -$10.33M 10-Q · filed 2026-08-10 | -$16.92M derived: sum of 3 quarters · filed 2026-08-10 | -$23.40M derived: sum of 4 quarters · filed 2026-08-10 | |||||
| 2026-03-31 | -$4.35M 10-Q · filed 2026-08-10 | -$10.94M derived: sum of 2 quarters · filed 2026-08-10 | -$17.42M derived: sum of 3 quarters · filed 2026-08-10 | -$23.11M derived: sum of 4 quarters · filed 2026-08-10 | |||||
| 2025-12-31 | -$6.59M derived: POS AM 12 month − 10-Q 9 month · filed 2026-06-12 | -$13.07M derived: sum of 2 quarters · filed 2026-06-12 | -$18.76M derived: sum of 3 quarters · filed 2026-08-10 | -$23.76M POS AM · filed 2026-06-12 | |||||
| 2025-09-30 | -$6.48M 10-Q · filed 2025-11-10 | -$12.17M derived: sum of 2 quarters · filed 2026-08-10 | -$17.17M 10-Q · filed 2025-11-10 | -$21.79M derived: sum of 4 quarters · filed 2026-08-10 | |||||
| 2025-06-30 | -$5.69M 10-Q · filed 2026-08-10 | -$10.69M 10-Q · filed 2026-08-10 | -$15.31M derived: sum of 3 quarters · filed 2026-08-10 | -$21.27M derived: sum of 4 quarters · filed 2026-08-10 | |||||
| 2025-03-31 | -$5.00M 10-Q · filed 2026-08-10 | -$9.62M derived: sum of 2 quarters · filed 2026-08-10 | -$15.58M derived: sum of 3 quarters · filed 2026-08-10 | -$19.52M derived: sum of 4 quarters · filed 2026-08-10 | |||||
| 2024-12-31 | -$4.62M derived: POS AM 12 month − 10-Q 9 month · filed 2026-06-12 | -$10.58M derived: sum of 2 quarters · filed 2026-06-12 | -$14.53M derived: sum of 3 quarters · filed 2026-06-12 | -$20.80M POS AM · filed 2026-06-12 | |||||
| 2024-09-30 | -$5.96M 10-Q · filed 2025-11-10 | -$9.91M derived: sum of 2 quarters · filed 2025-11-10 | -$16.18M 10-Q · filed 2025-11-10 | -$21.07M derived: sum of 4 quarters · filed 2025-11-10 | |||||
| 2024-06-30 | -$3.95M 10-Q · filed 2025-11-10 | -$10.22M 10-Q · filed 2025-07-31 | -$15.11M derived: sum of 3 quarters · filed 2025-11-10 | -$13.55M derived: sum of 4 quarters · filed 2025-11-10 | |||||
| 2024-03-31 | -$6.27M 10-Q · filed 2025-11-10 | -$11.16M derived: sum of 2 quarters · filed 2025-11-10 | -$9.60M derived: sum of 3 quarters · filed 2025-11-10 | -$22.94M derived: sum of 4 quarters · filed 2025-11-10 | |||||
| 2023-12-31 | -$4.89M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$3.33M derived: sum of 2 quarters · filed 2025-03-31 | -$16.67M derived: sum of 3 quarters · filed 2025-03-31 | -$29.92M 10-K · filed 2025-03-31 | -$29.91M 10-K · filed 2024-04-01 | ||||
| 2023-09-30 | $1.56M 10-Q · filed 2024-11-14 | -$11.77M derived: sum of 2 quarters · filed 2024-11-14 | -$25.03M 10-Q · filed 2024-11-14 | -$36.50M derived: sum of 4 quarters · filed 2024-11-14 | |||||
| 2023-06-30 | -$13.34M 10-Q · filed 2024-11-14 | -$1.14M 10-Q · filed 2023-08-14 | -$26.50M 10-Q · filed 2024-08-12 | -$420.54K 10-Q · filed 2023-08-14 | -$38.07M derived: sum of 3 quarters · filed 2024-11-14 | -$39.41M derived: sum of 4 quarters · filed 2024-11-14 | |||
| 2023-03-31 | -$13.25M 10-Q · filed 2024-11-14 | $717.70K 10-Q · filed 2023-05-15 | -$24.73M derived: sum of 2 quarters · filed 2024-11-14 | -$26.07M derived: sum of 3 quarters · filed 2024-11-14 | -$27.30M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2022-12-31 | -$11.48M derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-04-01 | -$12.82M derived: sum of 2 quarters · filed 2024-04-01 | -$14.05M derived: sum of 3 quarters · filed 2024-04-01 | -$15.92M 10-K · filed 2024-04-01 | $19.23M 10-K · filed 2023-04-03 | ||||
| 2022-09-30 | -$1.34M 10-Q/A · filed 2024-01-17 | $5.69M 10-Q · filed 2022-11-14 | -$2.58M derived: sum of 2 quarters · filed 2024-01-17 | -$4.45M 10-Q/A · filed 2024-01-17 | $21.24M 10-Q · filed 2022-11-14 | -$9.17M derived: sum of 4 quarters · filed 2024-01-17 | |||
| 2022-06-30 | -$1.24M 10-Q/A · filed 2024-01-17 | $3.09M 10-Q · filed 2022-08-15 | $15.55M 10-Q · filed 2023-08-14 | -$7.83M derived: sum of 3 quarters · filed 2024-01-17 | -$2.26M derived: sum of 4 quarters · filed 2024-01-17 | ||||
| 2022-03-31 | -$1.87M 10-Q/A · filed 2024-01-17 | $12.46M 10-Q · filed 2022-05-16 | -$6.59M derived: sum of 2 quarters · filed 2024-01-17 | -$1.02M derived: sum of 3 quarters · filed 2024-01-17 | -$652.20K derived: sum of 4 quarters · filed 2024-01-17 | ||||
| 2021-12-31 | -$4.72M derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-03 | $847.66K derived: sum of 2 quarters · filed 2023-04-03 | $1.22M derived: sum of 3 quarters · filed 2023-04-03 | -$251.63K 10-K · filed 2023-04-03 | |||||
| 2021-09-30 | $5.57M 10-Q · filed 2022-11-14 | $5.94M derived: sum of 2 quarters · filed 2022-11-14 | $4.47M 10-Q · filed 2022-11-14 | ||||||
| 2021-06-30 | $371.14K 10-Q · filed 2022-11-14 | -$1.10M 10-Q · filed 2022-08-15 | |||||||
| 2021-03-31 | -$1.47M 10-Q · filed 2022-11-14 | ||||||||
| 2020-12-31 | -$701.00 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| ENvue Medical, Inc. (FEED) | United States | $0.011B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| Bone Biologics Corp (BBLG) | United States | $0.001B | |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |